Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal.

Literature DB >> 28915107

Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal.

Pavel Soucek^1,2, David Vrana³, Yune-Fang Ueng^4,5,6, Shouzou Wei⁷, Renata Kozevnikovova⁸, Frederick Peter Guengerich⁹.

Abstract

Entities: Chemical

Keywords: breast cancer; estrogen; oxysterols; plasma; therapy

Mesh：

Substances：
Cholesterol

Year: 2018 PMID： 28915107 PMCID： PMC5792305 DOI： 10.1515/cclm-2017-0409

Source DB: PubMed Journal: Clin Chem Lab Med ISSN： 1434-6621 Impact factor: 8.490

× No keyword cloud information.

24 in total

1. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.

Authors: Erik R Nelson; Suzanne E Wardell; Jeff S Jasper; Sunghee Park; Sunil Suchindran; Matthew K Howe; Nicole J Carver; Ruchita V Pillai; Patrick M Sullivan; Varun Sondhi; Michihisa Umetani; Joseph Geradts; Donald P McDonnell
Journal: Science Date: 2013-11-29 Impact factor: 47.728

2. Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.

Authors: Yongjun Wang; Naresh Kumar; Laura A Solt; Timothy I Richardson; Leah M Helvering; Christine Crumbley; Ruben D Garcia-Ordonez; Keith R Stayrook; Xi Zhang; Scott Novick; Michael J Chalmers; Patrick R Griffin; Thomas P Burris
Journal: J Biol Chem Date: 2009-12-04 Impact factor: 5.157

Review 3. Cholesterol metabolism and resistance to tamoxifen.

Authors: Marc Poirot; Sandrine Silvente-Poirot; Ralph R Weichselbaum
Journal: Curr Opin Pharmacol Date: 2012-10-11 Impact factor: 5.547

4. Cancer statistics, 2016.

Authors: Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal: CA Cancer J Clin Date: 2016-01-07 Impact factor: 508.702

5. Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism.

Authors: Sara Boenzi; Federica Deodato; Roberta Taurisano; Bianca Maria Goffredo; Cristiano Rizzo; Carlo Dionisi-Vici
Journal: J Lipid Res Date: 2016-01-05 Impact factor: 5.922

Review 6. Oxysterols: From cholesterol metabolites to key mediators.

Authors: Valentin Mutemberezi; Owein Guillemot-Legris; Giulio G Muccioli
Journal: Prog Lipid Res Date: 2016-09-26 Impact factor: 16.195

7. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.

Authors: Gregory Segala; Philippe de Medina; Luigi Iuliano; Chiara Zerbinati; Michael R Paillasse; Emmanuel Noguer; Florence Dalenc; Bruno Payré; V Craig Jordan; Michel Record; Sandrine Silvente-Poirot; Marc Poirot
Journal: Biochem Pharmacol Date: 2013-03-07 Impact factor: 5.858

8. Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism.

Authors: P de Medina; B Payré; N Boubekeur; J Bertrand-Michel; F Tercé; S Silvente-Poirot; M Poirot
Journal: Cell Death Differ Date: 2009-06-12 Impact factor: 15.828

Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal.

1. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.

2. Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.

Review 3. Cholesterol metabolism and resistance to tamoxifen.

4. Cancer statistics, 2016.

5. Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism.

Review 6. Oxysterols: From cholesterol metabolites to key mediators.

7. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.

8. Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism.

9. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.

Review 10. Current trends in oxysterol research.

1. Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data.

Review 2. Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.